Growth-inhibitory effect of a fucoidan from brown seaweed Undaria pinnatifida on Plasmodium parasites.
The present study was undertaken to investigate the inhibitory effects of fucoidan, a sulfated polysaccharide isolated from the edible brown seaweed Undaria pinnatifida, on the growth of Plasmodium parasites. In order to assess the anti-malarial activity of fucoidan, growth inhibition activities were evaluated using cultured Plasmodium falciparum parasites in vitro and on Plasmodium berghei-infected mice in vivo. Fucoidan significantly inhibited the invasion of erythrocytes by P. falciparum merozoites, and its 50% inhibition concentration was similar to those for the chloroquine-sensitive P. falciparum 3D7 strain and the chloroquine-resistant K1 strain. Four-day suppressive testing in P. berghei-infected mice with fucoidan resulted in a 37% suppressive effect versus the control group and a delay in death associated with anemia (P < 0.05). In addition, fucoidans had no toxic effect on RAW 264.7 cells. These findings indicate that fucoidans from the Korean brown algae U. pinnatifida inhibits the invasion of Plasmodium merozoites into erythrocytes in vitro and in vivo.
Chen
Jun-Hu
JH
Department of Parasitology, Kangwon National University College of Medicine, Hyoja2-dong, Chunchon, 200-701 Gangwon-do, Republic of Korea.
Lim
Jung-Dae
JD
Sohn
Eun-Hwa
EH
Choi
Yong-Soon
YS
Han
Eun-Taek
ET
D000818:Animals; D000981:Antiprotozoal Agents / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use* / Q000633:toxicity; D002460:Cell Line; D020128:Inhibitory Concentration 50; D008264:Macrophages / Q000187:drug effects; D008288:Malaria / Q000188:drug therapy* / Q000469:parasitology; D051379:Mice; D008807:Mice, Inbred BALB C; D010961:Plasmodium / Q000187:drug effects / Q000254:growth & development*; D010962:Plasmodium berghei / Q000187:drug effects / Q000254:growth & development; D010963:Plasmodium falciparum / Q000187:drug effects / Q000254:growth & development; D011134:Polysaccharides / Q000302:isolation & purification / Q000494:pharmacology* / Q000627:therapeutic use* / Q000633:toxicity; D044648:Undaria / Q000737:chemistry*
D000981:Antiprotozoal Agents; D011134:Polysaccharides; C007789:fucoidan
Int Immunopharmacol. 2008 Jan;8(1):109-16
18068106
Glycobiology. 2003 Jun;13(6):29R-40R
12626402
Carbohydr Res. 2003 Jan 20;338(2):153-65
12526839
Cell. 2006 Feb 24;124(4):755-66
16497586
J Cell Biol. 1992 Jun;117(6):1351-7
1607393
Infect Immun. 1996 Apr;64(4):1373-8
8606103
In Vivo. 2003 May-Jun;17(3):245-9
12929574
Glycoconj J. 1997 Jun;14(4):473-9
9249145
Chem Pharm Bull (Tokyo). 2004 Sep;52(9):1091-4
15340195
Ann Trop Med Parasitol. 1975 Jun;69(2):155-71
1098584
J Biol Chem. 1991 Jul 25;266(21):13530-6
1906878
Eur J Biochem. 1991 Feb 14;195(3):789-94
1999196
Life Sci. 2007 Jan 30;80(8):775-81
17157323
Exp Parasitol. 1994 Dec;79(4):506-16
8001661
J Parasitol. 1979 Jun;65(3):418-20
383936
Toxicon. 2003 May;41(6):723-7
12727276
Science. 1976 Aug 20;193(4254):673-5
781840